You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resectable Hepatocellular Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Potentially Resectable Hepatocellular Carcinoma Trial (FOLFOX-HAIC+Lenvatinib+Envolizumab)

Not yet recruiting
  • Potentially Resectable Hepatocellular Carcinoma
  • (no location specified)
Nov 16, 2023

Resectable Hepatocellular Carcinoma Trial (Tislelizumab, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • (no location specified)
Mar 29, 2023

Resectable Hepatocellular Carcinoma Trial (Cadonilimab, TACE, Surgery)

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • (no location specified)
Dec 12, 2022

Hepatocellular Carcinoma Trial in Guangzhou (SIRT)

Not yet recruiting
  • Hepatocellular Carcinoma
  • SIRT
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Aug 9, 2023

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • (no location specified)
Jun 15, 2023

Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Boston (Durvalumab, Tremelimumab,

Not yet recruiting
  • Resectable Hepatocellular Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 18, 2023

Hepatocellular Carcinoma Trial in Beijing (Sintilimab, Lenvatinib, radiotherapy)

Recruiting
  • Hepatocellular Carcinoma
  • Beijing, Beijing, China
    Beijing Tsinghua Changgung Hospital
Jan 5, 2023

Hepatocellular Carcinoma Trial in Munich, Würzburg (durvalumab, tremelimumab, bevacizumab)

Recruiting
  • Hepatocellular Carcinoma
  • durvalumab, tremelimumab, bevacizumab
  • Munich, Germany
  • +2 more
May 3, 2023

Resectable Hepatocellular Carcinoma Trial in Jakarta Pusat (Liver Resection)

Completed
  • Resectable Hepatocellular Carcinoma
  • Liver Resection
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Dr. Cipto Mangunkusumo General Hospital
Aug 24, 2023

Hepatocellular Carcinoma Trial in France (QuiremSpheres)

Recruiting
  • Hepatocellular Carcinoma
  • QuiremSpheres
  • Clichy, France
  • +3 more
Jan 27, 2023

Plasma DNA Methylation in Peripheral Blood From Resectable Liver

Recruiting
  • Resectable Hepatocellular Carcinoma
  • Biospecimen Collection
  • Electronic Health Record Review
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Hepatocellular Carcinoma Trial in Jinan (PD-1 plus stereotactic body radiotherapy)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1 plus stereotactic body radiotherapy
  • Jinan, Shandong, China
    Shandong Cancer Hospital and Institute
May 3, 2022

Hepatocellular Carcinoma, Resectable Hepatocellular Carcinoma Trial in Boston (Atezolizumab, Bevacizumab, Stereotactic Beam

Recruiting
  • Hepatocellular Carcinoma
  • Resectable Hepatocellular Carcinoma
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 10, 2022

Carcinoma, Hepatocellular Trial in Shanghai (Pembrolizumab+Lenvatinib)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • Shanghai, Shanghai, China
    Zhongshan hospital
May 24, 2022

Resectable Hepatocellular Carcinoma Trial in Houston (Nivolumab, Pegargiminase, Resection)

Recruiting
  • Resectable Hepatocellular Carcinoma
  • Nivolumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 10, 2022

Hepatocellular Carcinoma, HCC, Liver Cancer Trial in Hong Kong (Nivolumab, Hepatectomy)

Completed
  • Hepatocellular Carcinoma
  • +2 more
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Jul 20, 2022

Hepatocellular Carcinoma Trial in Baltimore (Nivolumab, Relatlimab)

Recruiting
  • Hepatocellular Carcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 3, 2022

Hepatocellular Carcinoma Trial in United Kingdom (Pembrolizumab, Lenvatinib, Pembrolizumab and Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Birmingham, United Kingdom
  • +8 more
Apr 12, 2022

Primary Liver Cancer, Non-Resectable Hepatocellular Carcinoma Trial (MRI-guided radioembolization)

Not yet recruiting
  • Primary Liver Cancer
  • Non-Resectable Hepatocellular Carcinoma
  • MRI-guided radioembolization
  • (no location specified)
Nov 1, 2022

Hepatocellular Carcinoma Resectable Trial in Fuzhou (neoadjuvant therapy)

Not yet recruiting
  • Hepatocellular Carcinoma Resectable
  • neoadjuvant therapy
  • Fuzhou, Fujian, China
    The First Affiliated Hospital of Fujian Medical University
Aug 19, 2023

Hepatocellular Carcinoma Trial in Hangzhou (Apatinib Mesylate, Camrelizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Jan 16, 2022

Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial

Recruiting
  • Resectable Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +2 more
  • Houston, Texas
  • +1 more
Oct 12, 2022

Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • EYE90 Microspheres Treatment
  • (no location specified)
Jul 12, 2023

Hepatocellular Carcinoma Trial in Tianjin (HAIC, Sintilimab, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Nov 10, 2022

Hepatocellular Carcinoma Trial in Hangzhou (Sintilimab Injection, TACE, Radiotherapy)

Terminated
  • Hepatocellular Carcinoma
  • Sintilimab Injection
  • +2 more
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Dec 21, 2021